Publications Page Hero Image

Our industry-recognized Education team is committed to sharing program findings, best practices, insights, and trends from our educational programs across a range of therapeutic areas. These findings are regularly published in peer-reviewed journals, as well as presented at medical, patient, and industry conferences.

Tethered Education Helps Improve Diversity in Clinical Trials

Racial and ethnic disparities in clinical research leave many patients at a disadvantage, with lack of access to emerging therapies and lack of assurance that newly approved medications will be safe and effective for them. As one of its initiatives to help improve equitable representation in clinical trials, PlatformQ Health...

The Power of Continuing Medication Education to Enhance Health Care Providers’ Index of Suspicion of Rare Dermatologic Conditions

Education about rare diseases is crucial to reducing time to diagnosis and providing optimal care for patients. Recently, PlatformQ Health worked with our strategic partner the National Organization for Rare Disorders (NORD) to produce digital education for health care providers (HCPs), focused on the rare dermatological condition prurigo nodularis. The...

PlatformQ Health Secures Two Posters at 2023 American Academy of Neurology Annual Meeting

The digital education firm PlatformQ Health had two posters accepted at the 2023 American Academy of Neurology Annual Meeting, held in Boston from April 22-27, 2023. The company regularly shares outcomes from its health care provider (HCP) and patient-focused educational programs. During the annual meeting, PlatformQ Health’s posters focused on...

A Patient-Centric Outcomes Approach That Impacted 26 Million Patients in 2022 

PlatformQ Health had 20 posters accepted at major medical and healthcare conferences during 2022. We’re pleased to share the posters, highlighting key outcomes from our educational initiatives across an array of therapeutic areas. Oncology 2022 Alliance Industry Summit Supplemental Digital Resources  CME Program Closes Critical Knowledge Gap in Cancer Immunotherapy...

Online Education Sheds Light on Gaps in Care for Chronic Spontaneous Urticaria

Patients with chronic spontaneous urticaria (CSU) often suffer with unresolved symptoms, despite numerous visits to different healthcare providers. In a recent poster presented at the 2023 American Academy of Allergy, Asthma, and Immunology, PlatformQ Health evaluated the impact of digital continuing medical education (CME) on optimizing diagnosis as well as...

Four-part Digital Education Fosters Clinical Practice Changes in Gastric and Gastroesophageal Junction Adenocarcinomas

Gastric or gastroesophageal junction (GEJ) adenocarcinomas are notoriously difficult to treat, but recently approved immune checkpoint inhibitors and HER2-directed antibody drug conjugates are improving outcomes for patients with these conditions. While these advances are a positive change, they do pose challenges for healthcare providers who need to learn about new...

Tethered Education Identifies Gaps in TNBC Care and Perceptions

Vast racial disparities exist in triple-negative breast cancer (TNBC), yet many patients and providers are aware of these issues. Women of the African Diaspora (WAD) are often diagnosed at a more advanced stage and experience higher rates of TNBC-related mortality. Though the TNBC treatment landscape has changed with the influx...

Timelapse of Patient and Provider Surveys Reveals Valuable Insights for CLL Educational Needs

Targeted treatment regimens have significantly improved overall survival for patients with chronic lymphocytic leukemia (CLL). The emergence of new options such as BTK inhibitors has shifted the treatment landscape significantly, bringing a pressing need for education for providers, patients, and caregivers. This included a persistent need for: A better understanding...

Two-part Educational Program Improves Physician Competency in Immunotherapies

The growth of immunotherapies has shifted the standard of care for treating many solid tumors. As new indications are approved, there is a growing need for clinician education in this space. To that end, the Society for Immunotherapy of Cancer (SITC) and PlatformQ Health partnered to develop a two-part educational...

Patient Voice Helps Healthcare Providers Better Understand Treatment Expectations for Heart Condition

Early diagnosis and treatment of homozygous familial hypercholesterolemia (HoFH) are key to reducing patients' risk, yet there is low awareness of current guidelines and treatment options among healthcare practitioners. To address these challenges, the American Society for Preventive Cardiology, Mended Hearts, Mended Little Hearts, the National Lipid Association, and PlatformQ Health...